BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1968773)

  • 1. Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial.
    San L; Camí J; Peri JM; Mata R; Porta M
    Br J Addict; 1990 Jan; 85(1):141-7. PubMed ID: 1968773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inpatient heroin detoxification: a comment.
    Cook CC
    Br J Addict; 1989 Nov; 84(11):1369-71. PubMed ID: 2574603
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative effectiveness of alpha-2 adrenergic agonists (clonidine-guanfacine) in the hospital detoxification of opiate addicts].
    Muga R; Tor J; Forteza-Rei J; Jacas C; Altés J; Mestre L
    Med Clin (Barc); 1990 Feb; 94(5):169-72. PubMed ID: 1969980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Success and failure at inpatient heroin detoxification.
    San L; Camí J; Peri JM; Mata R; Porta M
    Br J Addict; 1989 Jan; 84(1):81-7. PubMed ID: 2644999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002024. PubMed ID: 15495025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of heroin withdrawal with guanfacine: an open clinical investigation.
    Soler Insa PA; Bedate Villar J; Theohar C; Yotis A
    Can J Psychiatry; 1987 Nov; 32(8):679-82. PubMed ID: 2891431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
    Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha₂-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White JM
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD002024. PubMed ID: 27140827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2001; (1):CD002024. PubMed ID: 11279747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha2-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell MF; Ali R; White JM
    Cochrane Database Syst Rev; 2014 Mar; (3):CD002024. PubMed ID: 24683051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2003; (2):CD002024. PubMed ID: 12804419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of presynaptic alpha-mimetics for withdrawal in heroin addicts].
    Gorceix A; Dugarin J; Pommier F
    Ann Med Interne (Paris); 1985; 136(5):389-92. PubMed ID: 2865924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular parameters of heroin-withdrawn addicts treated with guanfacine.
    Rubio G; Alguacil LF; Alamo C; López-Muñoz F; Pascual J; López-Trabada JR
    Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):189-92. PubMed ID: 9203168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts.
    Camí J; Gilabert M; San L; de la Torre R
    Br J Addict; 1992 Aug; 87(8):1145-51. PubMed ID: 1511228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detoxification in withdrawal state in methadone maintenance patients].
    Sivolap I; Savchenkov VA; Aksel'rod BA; Kubarev DA; Chichenkov TO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):33-7. PubMed ID: 14681963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha2-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White JM
    Cochrane Database Syst Rev; 2009 Apr; (2):CD002024. PubMed ID: 19370574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha2-adrenergic agonists in opioid withdrawal.
    Gowing LR; Farrell M; Ali RL; White JM
    Addiction; 2002 Jan; 97(1):49-58. PubMed ID: 11895270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension.
    Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P
    Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies with alpha 2-adrenoceptor agonists and alcohol abstinence syndrome in rats.
    Parale MP; Kulkarni SK
    Psychopharmacology (Berl); 1986; 88(2):237-9. PubMed ID: 2869542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.